On November 02, 2017, Annoroad announced the completion of its latest round of financing (nearly $105 million). This round of investment has been co-led by GTJA Investment Group and Ping An Ventures, other investors like SBCVC, SAIF Partners China, etc. are also involved. Annoroad is focusing on the industrialized application of new-generation genomics technology […]
The Qlucore NGS module has now been available for more than a month and the user feedback is very positive. As always, Qlucore is striving to provide a fast and easy to use analysis tool with instant responses to your analysis settings. In an exciting and seamless way, you can now use the Genome browser, […]
TwistDx’s recently launched range of liquid format Recombinase Polymerase Amplification (RPA) kits are ideal for rapid testing applications and high throughput laboratory use. This isothermal DNA/RNA amplification technology represents a versatile solution for nucleic acid detection, offering the same specificity as PCR but much faster results – typically within three to 10 minutes. The newly […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (NASDAQ:PACB) announced today that Kathy Ordoñez has been named Chief Commercial Officer and Executive Vice President. Ms. Ordoñez brings more than thirty years of experience in the life sciences and diagnostics industries, with senior roles at Hoffmann-La Roche, Celera, Quest Diagnostics and RainDance Technologies. At Roche, Kathy was responsible for […]
Thermo Fisher’s multi-biomarker test helps match lung cancer patients to FDA-approved therapies in days instead of weeks CGI and Thermo Fisher are collaborating with pharmaceutical partners and clinical cancer centers to drive adoption and improve therapy selection process Oncomine Dx Target Test eliminates time-consuming, single-biomarker testing approach by simultaneously screening patient tumor samples for 23 […]
LGC LINK, the oligonucleotide synthesis reagent manufacturing part of LGC’s Genomics division, and MiNA Therapeutics, the pioneer in RNA activation therapeutics, today announced that Innovate UK has awarded the two companies a grant to develop liver targeted gene activation therapies for the treatment of liver diseases. The grant of up to approximately £400,000, with additional funding from […]
The Translational Research Institute (TRI), Brisbane has become the first centre in Australia and the Asia Pacific region to adopt the Livecyte™ Cell Imaging and Analysis system. TRI was formed to enhance collaboration between science, healthcare and industry with the purpose of accelerating the application of innovative scientific research to improve healthcare outcomes. The Institute, […]
TwistDx’s recently launched range of liquid format Recombinase Polymerase Amplification (RPA) kits are ideal for rapid testing applications and high throughput laboratory use. This isothermal DNA/RNA amplification technology represents a versatile solution for nucleic acid detection, offering the same specificity as PCR but much faster results – typically within three to 10 minutes. The newly […]
Feeling limited and underwhelmed by your flow cytometer automation? Stratedigm’s all new Open API gives you the freedom you deserve and the future-proof growth you need. There are many components that can be apart of an automation system like shakers, liquid handlers, incubators, storage, schedulers, and analyzers. And with Stratedigm’s Open API, you can expand […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
